RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 May 2010 | By

Recently, the US Food and Drug Administration (FDA) launched FDA-TRACK, a performance management program that will monitor key performance metrics for 100 FDA program offices. The objectives of this program can be explained by its name: "TRACK" stands for Transparency, Results, Accountability, Credibility and Knowledge sharing. The goal is to provide the public a closer look into how the agency works, create more accountability within the offices and share information about FDA performance. The performance metrics, which are posted online on the FDA-TRACK dashboard, have been developed by the program offices and are reported on a monthly basis. Each quarter, monthly performance data are analyzed and senior managers present them to FDA senior leadership.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.